Dart AM, Kingwell BA. Pulse pressure–a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37(4):975–84.
Article
CAS
Google Scholar
Safar M. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15(2):97–105.
Article
Google Scholar
Van Bortel L, Struijker-Boudier H, Safar M. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension. 2001;38(4):914–21.
Article
Google Scholar
Pancholy S, Shantha G, Patel T, Sobotka P, Kandzari D. Meta-analysis of the effect of renal denervation on blood pressure and pulse pressure in patients with resistant systemic hypertension. Am J Cardiol. 2014;114(6):856–61.
Article
Google Scholar
Jaźwiec P, Gać P, Poręba M, Sobieszczańska M, Mazur G, Poręba R. The volume of the carotid bodies and blood pressure variability and pulse pressure in patients with essential hypertension. Clin Radiol. 2016;71(6):616.e617-616.e613.
Article
Google Scholar
Wang Y, Wang JG. Genome-wide association studies of hypertension and several other cardiovascular diseases. Pulse (Basel). 2019;6(3–4):169–86.
Google Scholar
Gilham D, Tsujikawa L, Sarsons C, Halliday C, Wasiak S, Stotz S, Jahagirdar R, Sweeney M, Johansson J, Wong N, et al. Apabetalone downregulates factors and pathways associated with vascular calcification. Atherosclerosis. 2019;280:75–84.
Article
CAS
Google Scholar
Liong S, Barker G, Lappas M. Bromodomain protein BRD4 is increased in human placentas from women with early-onset preeclampsia. Reproduction. 2018;155(6):573–82.
Article
CAS
Google Scholar
Chiasson V, Munshi N, Chatterjee P, Young K, Mitchell B. Pin1 deficiency causes endothelial dysfunction and hypertension. Hypertension. 2011;58(3):431–8.
Article
CAS
Google Scholar
McLure K, Gesner E, Tsujikawa L, Kharenko O, Attwell S, Campeau E, Wasiak S, Stein A, White A, Fontano E, et al. RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist. PLoS ONE. 2013;8(12):e83190.
Article
Google Scholar
Brown J, Lin C, Duan Q, Griffin G, Federation A, Paranal R, Bair S, Newton G, Lichtman A, Kung A, et al. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell. 2014;56(2):219–31.
Article
CAS
Google Scholar
Lv L, Ye M, Duan R, Yuan K, Chen J, Liang W, Zhou Z, Zhang L. Downregulation of Pin1 in human atherosclerosis and its association with vascular smooth muscle cell senescence. J Vasc Surg. 2018;68(3):873-883.e875.
Article
Google Scholar
Liu M, Yu P, Jiang H, Yang X, Zhao J, Zou Y, Ge J. The Essential role of Pin1 via NF-κB signaling in vascular inflammation and atherosclerosis in ApoE mice. Int J Mol Sci. 2017;18(3):644.
Article
Google Scholar
Zeng K, Wu X, Cai H, Gao Y, Li G, Liu Q, Gao F, Chen J, Lin C. Correlation between the NPPB gene promoter c.-1298 G/T polymorphism site and pulse pressure in the Chinese Han population. Genet Mol Res. 2014;13(2):3265–74.
Article
CAS
Google Scholar
Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (https://analysis.bio-x.cn/). Cell Res. 2009;19(4):519–23.
Shi Y, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–8.
Article
CAS
Google Scholar
Boyle A, Hong E, Hariharan M, Cheng Y, Schaub M, Kasowski M, Karczewski K, Park J, Hitz B, Weng S, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–7.
Article
CAS
Google Scholar
Stokes L, Scurrah K, Ellis J, Cromer B, Skarratt K, Gu B, Harrap S, Wiley J. A loss-of-function polymorphism in the human P2X4 receptor is associated with increased pulse pressure. Hypertension. 2011;58(6):1086–92.
Article
CAS
Google Scholar
Engelen L, Ferreira I, Brouwers O, Henry RM, Dekker JM, Nijpels G, Heine RJ, van Greevenbroek MM, van der Kallen CJ, Blaak EE, et al. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J Hypertens. 2009;27(7):1399–403.
Article
CAS
Google Scholar
Wang B, Zhang M, Takayama T, Shi X, Roenneburg D, Kent K, Guo L. BET bromodomain blockade mitigates intimal hyperplasia in rat carotid arteries. EBioMedicine. 2015;2(11):1650–61.
Article
Google Scholar
Meloche J, Lampron M, Nadeau V, Maltais M, Potus F, Lambert C, Tremblay E, Vitry G, Breuils-Bonnet S, Boucherat O, et al. Implication of inflammation and epigenetic readers in coronary artery remodeling in patients with pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol. 2017;37(8):1513–23.
Article
CAS
Google Scholar
Chen J, Fu Y, Day D, Sun Y, Wang S, Liang X, Gu F, Zhang F, Stevens S, Zhou P, et al. VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis. Nat Commun. 2017;8(1):383.
Article
CAS
Google Scholar
Huang M, Qiu Q, Xiao Y, Zeng S, Zhan M, Shi M, Zou Y, Ye Y, Liang L, Yang X, et al. BET bromodomain suppression inhibits VEGF-induced angiogenesis and vascular permeability by blocking VEGFR2-mediated activation of PAK1 and eNOS. Sci Rep. 2016;6:23770.
Article
CAS
Google Scholar
Sun Y, Xie Y, Du L, Sun J, Liu Z. Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF-κB pathway in a rat model of myocardial infarction. Cardiovasc Ther. 2018;36(2):e12320.
Article
Google Scholar
Yasuno S, Ueshima K, Oba K, Fujimoto A, Hirata M, Ogihara T, Saruta T, Nakao K. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: A subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Diabetes Care. 2010;33(5):1122–7.
Article
Google Scholar
Zhang L, Wang B, Wang C, Li L, Ren Y, Zhang H, Yang X, Zhao Y, Han C, Zhou J, et al. High pulse pressure is related to risk of type 2 diabetes mellitus in Chinese middle-aged females. Int J Cardiol. 2016;220:467–71.
Article
Google Scholar